pmc logo imageJournal ListSearchpmc logo image
Logo of gutJournal URL: redirect3.cgi?&&auth=0tKcNBFZoDuSVYdy5M7VgdCyKVt0lI7zxoOQwhAqm&reftype=publisher&artid=1412970&article-id=1412970&iid=129371&issue-id=129371&jid=158&journal-id=158&FROM=Article|Banner&TO=Publisher|Other|N%2FA&rendering-type=normal&&http://gut.bmj.com
Journal List > Gut > v.15(7); Jul 1974
>Summary
Selected References
Page Browse
PDF (2.1M)
Contents
Archive

PubMed articles by:
Sherlock, S.
Gut. 1974 July; 15(7): 581–597.
PMCID: PMC1412970
Copyright notice
Chronic hepatitis.
S Sherlock
Small right arrow pointing to: This article has been cited by other articles in PMC.
Full text
Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (2.1M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
icon of scanned page 581
581
icon of scanned page 582
582
icon of scanned page 583
583
icon of scanned page 584
584
 
icon of scanned page 585
585
icon of scanned page 586
586
icon of scanned page 587
587
icon of scanned page 588
588
 
icon of scanned page 589
589
icon of scanned page 590
590
icon of scanned page 591
591
icon of scanned page 592
592
 
icon of scanned page 593
593
icon of scanned page 594
594
icon of scanned page 595
595
icon of scanned page 596
596
 
icon of scanned page 597
597
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
  • Summerskill, WH. Chronic active liver disease reexamined: prognosis hopeful. Gastroenterology. 1974 Mar;66(3):450–464. [PubMed]
  • Reynolds, TB; Peters, RL; Yamada, S. Chronic active and lupoid hepatitis caused by a laxative, oxyphenisatin. N Engl J Med. 1971 Oct 7;285(15):813–820. [PubMed]
  • Elkington, SG; Schreiber, WM; Conn, HO. Hepatic injury caused by L-alpha-methyldopa. Circulation. 1969 Oct;40(4):589–595. [PubMed]
  • Maddrey, WC; Boitnott, JK. Isoniazid hepatitis. Ann Intern Med. 1973 Jul;79(1):1–12. [PubMed]
  • Sternlieb, I; Scheinberg, IH. Chronic hepatitis as a first manifestation of Wilson's disease. Ann Intern Med. 1972 Jan;76(1):59–64. [PubMed]
  • Berg, NO; Eriksson, S. Liver disease in adults with alpha-1 -antitrypsin deficiency. N Engl J Med. 1972 Dec 21;287(25):1264–1267. [PubMed]
  • De Groote, J; Desmet, VJ; Gedigk, P; Korb, G; Popper, H; Poulsen, H; Scheuer, PJ; Schmid, M; Thaler, H; Uehlinger, E. A classification of chronic hepatitis. Lancet. 1968 Sep 14;2(7568):626–628. [PubMed]
  • Becker, MD; Baptista, A; Scheuer, PJ; Sherlock, S. Prognosis of chronic persistent hepatitis. Lancet. 1970 Jan 10;1(7637):53–57. [PubMed]
  • Sherlock, S; Fox, RA; Niazi, SP; Scheuer, PJ. Chronic liver disease and primary liver-cell cancer with hepatitis-associated (Australia) antigen in serum. Lancet. 1970 Jun 13;1(7659):1243–1247. [PubMed]
  • Vido, I; Selmair, H; Wildhirt, E; Ortmans, H. Zur Prognose der chronischen Hepatitis. 1. Formen und Entwicklungsstadien. Dtsch Med Wochenschr. 1969 Oct 24;94(43):2215–passim. [PubMed]
  • Palmer, PE; Wolfe, HJ; Gherardi, GJ. Hepatic changes in adult alpha-1-antitrypsin deficiency. Gastroenterology. 1973 Aug;65(2):284–293. [PubMed]
  • Mistilis, SP; Blackburn, CR. Active chronic hepatitis. Am J Med. 1970 Apr;48(4):484–495. [PubMed]
  • BEARN, AG; KUNKEL, HG; SLATER, RJ. The problem of chronic liver disease in young women. Am J Med. 1956 Jul;21(1):3–15. [PubMed]
  • COWLING, DC; MACKAY, IR; TAFT, LI. Lupoid hepatitis. Lancet. 1956 Dec 29;271(6957):1323–1326. [PubMed]
  • PAGE, AR; GOOD, RA. Plasma-cell hepatitis, with special attention to steroid therapy. AMA J Dis Child. 1960 Mar;99:288–314. [PubMed]
  • READ, AE; SHERLOCK, S; HARRISON, CV. ACTIVE 'JUVENILE' CIRRHOSIS CONSIDERED AS PART OF A SYSTEMIC DISEASE AND THE EFFECT OF CORTICOSTEROID THERAPY. Gut. 1963 Dec;4:378–393. [PubMed]
  • CATTAN, R; VESIN, P; BODIN, H. Cirrhoses dysprotéinémiques d'origine inconnue chez la femme. Bull Mem Soc Med Hop Paris. 73(20-21):608–616. [PubMed]
  • BOUCHIER, IA; RHODES, K; SHERLOCK, S. SEROLOGICAL ABNORMALITIES IN PATIENTS WITH LIVER DISEASE. Br Med J. 1964 Mar 7;1(5383):592–594. [PubMed]
  • Doniach, D; Roitt, IM; Walker, JG; Sherlock, S. Tissue antibodies in primary biliary cirrhosis, active chronic (lupoid) hepatitis, cryptogenic cirrhosis and other liver diseases and their clinical implications. Clin Exp Immunol. 1966 Jul;1(3):237–262. [PubMed]
  • Johnson, GD; Holborow, EJ; Glynn, LE. Antibody to smooth muscle in patients with liver disease. Lancet. 1965 Oct 30;2(7418):878–879. [PubMed]
  • Whittingham, S; Mackay, IR; Irwin, J. Autoimmune hepatitis. Immunofluorescence reactions with cytoplasm of smooth muscle and renal glomerular cells. Lancet. 1966 Jun 18;1(7451):1333–1335. [PubMed]
  • WALKER, JG; DONIACH, D; ROITT, IM; SHERLOCK, S. SEROLOGICAL TESTS IN DIAGNOSIS OF PRIMARY BILIARY CIRRHOSIS. Lancet. 1965 Apr 17;1(7390):827–831. [PubMed]
  • ASHERSON, GL. Antibodies against nuclear and cytoplasmic cell constituents in systemic lupus erythematosus and other diseases. Br J Exp Pathol. 1959 Jun;40(3):209–215. [PubMed]
  • GAJDUSEK, DC. An autoimmune reaction against human tissue antigens in certain acute and chronic diseases. I. Serological investigations. AMA Arch Intern Med. 1958 Jan;101(1):9–29. [PubMed]
  • MUSCHEL, LH; SIMONTON, LA; WELLS, PA; FIFE, EH., Jr Occurrence of complement-fixing antibodies reactive with normal tissue constituents in normal and disease states. J Clin Invest. 1961 Mar;40:517–524. [PubMed]
  • Doniach, D; Walker, JG. A unified concept of autoimmune hepatitis. Lancet. 1969 Apr 19;1(7599):813–815. [PubMed]
  • MUSCHEL, LH; SIMONTON, LA; WELLS, PA; FIFE, EH., Jr Occurrence of complement-fixing antibodies reactive with normal tissue constituents in normal and disease states. J Clin Invest. 1961 Mar;40:517–524. [PubMed]
  • PASNICK, LJ; BEALL, GN; VANARSDEL, PP., Jr Complement fixing reactions with liver tissue in human disease. Am J Med. 1962 Nov;33:774–782. [PubMed]
  • Rössler, R; Havemann, K; Dölle, W. Unterschiedliche Reaktion von Lymphocyten auf Phythämagglutinin (PHA) bei Lebererkrankungen. Klin Wochenschr. 1969 Aug 1;47(15):803–806. [PubMed]
  • Tobias, H; Safran, AP; Schaffner, F. Lymphocyte stimulation and chronic liver disease. Lancet. 1967 Jan 28;1(7483):193–195. [PubMed]
  • Toh, BH; Roberts-Thomson, IC; Mathews, JD; Whittingham, S; Mackay, IR. Depression of cell-mediated immunity in old age and the immunopathic diseases, lupus erythematosus, chronic hepatitis and rheumatoid arthritis. Clin Exp Immunol. 1973 Jun;14(2):193–202. [PubMed]
  • Bulkley, BH; Goldfinger, SE; Heizer, WD; Isselbacher, KJ; Shulman, NR. Distinctions in chronic active hepatitis based on circulating hepatitis-associated antigen. Lancet. 1970 Dec 26;2(7687):1323–1326. [PubMed]
  • Fox, RA; Niazi, SP; Sherlock, S. Hepatitis-associated antigen in chronic liver disease. Lancet. 1969 Sep 20;2(7621):609–612. [PubMed]
  • Mathews, JD; Mackay, IR. Australia antigen in chronic hepatitis in Australia. Br Med J. 1970 Jan 31;1(5691):259–261. [PubMed]
  • CAVELL, B; LEONHARDT, T. HEREDITARY HYPERGAMMAGLOBULINEMIA AND LUPOID HEPATITIS. Acta Med Scand. 1965 Jun;177:751–759. [PubMed]
  • Joske, RA; Laurence, BH. Familial cirrhosis with autoimmune features and raised immunoglobulin levels. Gastroenterology. 1970 Oct;59(4):546–552. [PubMed]
  • Feizi, T; Naccarato, R; Sherlock, S; Doniach, D. Mitochondrial and other tissue antibodies in relatives of patients with primary biliary cirrhosis. Clin Exp Immunol. 1972 Apr;10(4):609–622. [PubMed]
  • Elling, P; Ranlov, P; Bildsoe, P. A genetic approach to the pathogenesis of hepatic cirrhosis. A clinical and serological study. Acta Med Scand. 1966 May;179(5):527–533. [PubMed]
  • Galbraith, RM; Smith, M; Mackenzie, RM; Tee, DE; Doniach, D; Williams, R. High prevalence of seroimmunologic abnormalities in relatives of patients with active chronic hepatitis or primary biliary cirrhosis. N Engl J Med. 1974 Jan 10;290(2):63–69. [PubMed]
  • Mackay, IR; Morris, PJ. Association of autoimmune active chronic hepatitis with HL-A1,8. Lancet. 1972 Oct 14;2(7781):793–795. [PubMed]
  • Cooksley, WG; Powell, LW; Kerr, JF; Bhathal, PS. Cholestasis in active chronic hepatitis. Am J Dig Dis. 1972 Jun;17(6):495–504. [PubMed]
  • WILLOCX, RG; ISSELBACHER, KJ. Chronic liver disease in young people. Clinical features and course in thirty-three patients. Am J Med. 1961 Feb;30:185–195. [PubMed]
  • Mistilis, SP; Blackburn, CR. The treatment of active chronic hepatitis with 6-mercaptopurine and azathioprine. Australas Ann Med. 1967 Nov;16(4):305–311. [PubMed]
  • Sarkany, I. Juvenile cirrhosis and allergic capillaritis of the skin. A hepato-cutaneous syndrome. Lancet. 1966 Sep 24;2(7465):666–668. [PubMed]
  • MACLACHLAN, MJ; RODNAN, GP; COOPER, WM; FENNELL, RH., Jr CHRONIC ACTIVE ("LUPOID") HEPATITIS; A CLINICAL, SEROLOGICAL, AND PATHOLOGICAL STUDY OF 20 PATIENTS. Ann Intern Med. 1965 Mar;62:425–462. [PubMed]
  • Bridi, GS; Falcon, PW; Brackett, NC, Jr; Still, WJ; Sporn, IN. Glomerulonephritis and renal tubular acidosis in a case of chronic active hepatitis with hyperimmunoglobulinemia. Am J Med. 1972 Feb;52(2):267–278. [PubMed]
  • SILVA, H; HALL, EW; HILL, KR; SHALDON, S; SHERLOCK, S. RENAL INVOLVEMENT IN ACTIVE "JUVENILE" CIRRHOSIS. J Clin Pathol. 1965 Mar;18:157–163. [PubMed]
  • Morris, RC., Jr Renal tubular acidosis. Mechanisms, classification and implications. N Engl J Med. 1969 Dec 18;281(25):1405–1413. [PubMed]
  • Golding, PL; Smith, M; Williams, R. Multisystem involvement in chronic liver disease. Studies on the incidence and pathogenesis. Am J Med. 1973 Dec;55(6):772–782. [PubMed]
  • Golding, PL; Mason, AS. Renal tubular acidosis and autoimmune liver disease. Gut. 1971 Feb;12(2):153–157. [PubMed]
  • CHRISPIN, AR; LESSOF, L. THE CHEST RADIOGRAPH IN "JUVENILE" CIRRHOSIS (ACTIVE CHRONIC HEPATITIS). Br J Radiol. 1965 Sep;38:685–690. [PubMed]
  • Berthelot, P; Walker, JG; Sherlock, S; Reid, L. Arterial changes in the lungs in cirrhosis of the liver--lung spider nevi. N Engl J Med. 1966 Feb 10;274(6):291–298. [PubMed]
  • Stanley, NN; Woodgate, DJ. The circulation, the lung, and finger clubbing in hepatic cirrhosis. Br Heart J. 1971 Jul;33(4):469–472. [PubMed]
  • Turner-Warwick, M. Fibrosing alveolitis and chronic liver disease. Q J Med. 1968 Jan;37(145):133–149. [PubMed]
  • COHEN, N; MENDELOW, H. CONCURRENT "ACTIVE JUVENILE CIRRHOSIS" AND "PRIMARY PULMONARY HYPERTENSION". Am J Med. 1965 Jul;39:127–133. [PubMed]
  • Boxer, LA; Yokoyama, M; Wiebe, RA. Autoimmune neutropenia associated with chronic active hepatitis. Am J Med. 1972 Feb;52(2):279–282. [PubMed]
  • HOLDSWORTH, CD; HALL, EW; DAWSON, AM; SHERLOCK, S. ULCERATIVE COLITIS IN CHRONIC LIVER DISEASE. Q J Med. 1965 Apr;34:211–227. [PubMed]
  • Golding, PL; Bown, R; Mason, AM; Taylor, E. "Sicca complex" in liver disease. Br Med J. 1970 Nov 7;4(5731):340–342. [PubMed]
  • ASHERSON, GL. Antibodies against nuclear and cytoplasmic cell constituents in systemic lupus erythematosus and other diseases. Br J Exp Pathol. 1959 Jun;40(3):209–215. [PubMed]
  • Feizi, T. Immunoglobulins in chronic liver disease. Gut. 1968 Apr;9(2):193–198. [PubMed]
  • Cook, GC; Mulligan, R; Sherlock, S. Controlled prospective trial of corticosteroid therapy in active chronic hepatitis. Q J Med. 1971 Apr;40(158):159–185. [PubMed]
  • Cook, GC; Velasco, M; Sherlock, S. Effect of corticosteroid therapy on bromsulphthalein excretion in active chronic hepatitis. Gut. 1968 Jun;9(3):270–283. [PubMed]
  • Soloway, RD; Summerskill, WH; Baggenstoss, AH; Geall, MG; Gitnićk, GL; Elveback, IR; Schoenfield, LJ. Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis. Gastroenterology. 1972 Nov;63(5):820–833. [PubMed]
  • Mackay, IR. Chronic hepatitis: effect of prolonged suppressive treatment and comparison of azathioprine with prednisolone. Q J Med. 1968 Jul;37(147):379–392. [PubMed]
  • Page, AR; Good, RA; Pollara, B. Long-term results of therapy in patients with chronic liver disease associated with hypergammaglobulinemia. Am J Med. 1969 Nov;47(5):765–774. [PubMed]
  • Murray-Lyon, IM; Stern, RB; Williams, R. Controlled trial of prednisone and azathioprine in active chronic hepatitis. Lancet. 1973 Apr 7;1(7806):735–737. [PubMed]
  • Whelan, G; Sherlock, S. Immunosuppressive activity in patients with active chronic hepatitis and primary biliary cirrhosis treated with azathioprine. Gut. 1972 Nov;13(11):907–914. [PubMed]
  • Cooksley, WG; Powell, LW. Drug metabolism and interaction with particular reference to the liver. Drugs. 1971;2(3):177–189. [PubMed]
  • Powell, LW; Axelsen, E. Corticosteroids in liver disease: studies on the biological conversion of prednisone to prednisolone and plasma protein binding. Gut. 1972 Sep;13(9):690–696. [PubMed]
  • Hourigan, K; Sherlock, S; George, P; Mindel, S. Elective end-to-side portacaval shunt: results in 64 cases. Br Med J. 1971 Nov 20;4(5785):473–477. [PubMed]
  • Walker, JG; Doniach, D; Doniach, I. Mitochondrial antibodies and subclinical liver disease. Q J Med. 1970 Jan;39(153):31–48. [PubMed]
  • Fox, RA; Niazi, SP; Sherlock, S. Hepatitis-associated antigen in chronic liver disease. Lancet. 1969 Sep 20;2(7621):609–612. [PubMed]
  • Wright, R; McCollum, RW; Klatskin, G. Australia antigen in acute and chronic liver disease. Lancet. 1969 Jul 19;2(7612):117–121. [PubMed]
  • Hadziyannis, S; Gerber, MA; Vissoulis, C; Popper, H. Cytoplasmic hepatitis B antigen in "ground-glass" hepatocytes of carriers. Arch Pathol. 1973 Nov;96(5):327–330. [PubMed]
  • Le Bouvier, GL. Editorial: Subtypes of hepatitis B antigen: clinical relevance? Ann Intern Med. 1973 Dec;79(6):894–896. [PubMed]
  • Almeida, JD; Waterson, AP. Immune complexes in hepatitis. Lancet. 1969 Nov 8;2(7628):983–986. [PubMed]
  • Dudley, FJ; Fox, RA; Sherlock, S. Cellular immunity and hepatitis-associated, Australia antigen liver disease. Lancet. 1972 Apr 1;1(7753):723–726. [PubMed]
  • Dudley, FJ; Giustino, V; Sherlock, S. Cell-mediated immunity in patients positive for hepatitis-associated antigen. Br Med J. 1972 Dec 30;4(5843):754–756. [PubMed]
  • Dudley, FJ; O'Shea, MJ; Sherlock, S. Serum autoantibodies in hepatitis associated antigen (HAA) positive patients. A possible index of cell-mediated immunity to the associated-infective agent. Clin Exp Immunol. 1973 Mar;13(3):367–372. [PubMed]
  • Dudley, FJ; O'Shea, MJ; Ajdukiewicz, A; Sherlock, S. Serum autoantibodies and immunoglobulins in hepatitis-associated antigen (HAA)-positive and -negative liver disease. Gut. 1973 May;14(5):360–364. [PubMed]
  • Schweitzer, IL; Mosley, JW; Ashcaval, M; Edwards, VM; Overby, LB. Factors influencing neonatal infection by hepatitis B virus. Gastroenterology. 1973 Aug;65(2):277–283. [PubMed]
  • Dudley, FJ; Fox, RA; Sherlock, S. Relationship of hepatitis-associated antigen (H.A.A.) to acute and chronic liver injury. Lancet. 1971 Jul 3;2(7714):1–3. [PubMed]
  • Dudley, FJ; Scheuer, PJ; Sherlock, S. Natural history of hepatitis-associated antigen-positive chronic liver disease. Lancet. 1972 Dec 30;2(7792):1388–1393. [PubMed]
  • FRANKLIN, M; BEAN, WB; PAUL, WD; ROUTH, JI; HUERGA, J de la; POPPER, H. Electrophoretic studies in liver disease. II. Gamma globulin in chronic liver disease. J Clin Invest. 1951 Jul;30(7):729–737. [PubMed]
  • Goldstein, GB; Lam, KC; Mistilis, SP. Drug-induced active chronic hepatitis. Am J Dig Dis. 1973 Mar;18(3):177–184. [PubMed]
  • Rehman, OU; Keith, TA; Gall, EA. Methyldopa-induced submassive hepatic necrosis. JAMA. 1973 Jun 4;224(10):1390–1392. [PubMed]
  • Palmer, PE; Wolfe, HJ; Gherardi, GJ. Hepatic changes in adult alpha-1-antitrypsin deficiency. Gastroenterology. 1973 Aug;65(2):284–293. [PubMed]
Articles from Gut are provided here courtesy of
BMJ Group